Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:dissolved |
2007
|
| gptkbp:founded |
1678
|
| gptkbp:founder |
gptkb:Chobei_Tanabe
|
| gptkbp:headquarters_location |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tanabe Seiyaku
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:mergedInto |
gptkb:Mitsubishi_Tanabe_Pharma
|
| gptkbp:nativeName |
gptkb:田辺製薬株式会社
|
| gptkbp:notableProduct |
immunosuppressants
antihypertensive drugs antidiabetic drugs |
| gptkbp:officialWebsite |
https://www.mt-pharma.co.jp/
|
| gptkbp:parentOrganization |
gptkb:Mitsubishi_Chemical_Holdings
|
| gptkbp:stockExchange |
gptkb:Osaka_Securities_Exchange
gptkb:Tokyo_Stock_Exchange |
| gptkbp:successor |
gptkb:Mitsubishi_Tanabe_Pharma
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:bfsParent |
gptkb:Mitsubishi_Tanabe_Pharma
|
| gptkbp:bfsLayer |
6
|